These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1646668)

  • 1. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents.
    Pontecorvo MJ; Karbon EW; Goode S; Clissold DB; Borosky SA; Patch RJ; Ferkany JW
    Brain Res Bull; 1991 Mar; 26(3):461-5. PubMed ID: 1646668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L; Wong EH; Kesingland AC; Tricklebank MD
    Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of N-methyl-D-aspartate-induced brain injury in an in vivo perinatal rat model.
    McDonald JW; Johnston MV
    Synapse; 1990; 6(2):179-88. PubMed ID: 1978420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine.
    Rogawski MA; Yamaguchi S; Jones SM; Rice KC; Thurkauf A; Monn JA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):30-7. PubMed ID: 1920122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies.
    Lockhart BP; Soulard P; Benicourt C; Privat A; Junien JL
    Brain Res; 1995 Mar; 675(1-2):110-20. PubMed ID: 7796119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands.
    Rao TS; Mick SJ; Cler JA; Emmett MR; Dilworth VM; Contreras PC; Gray NM; Wood PL; Iyengar S
    Brain Res; 1991 Oct; 561(1):43-50. PubMed ID: 1686745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors.
    Hornfeldt CS; Kitto KF; Larson AA
    Eur J Pharmacol; 1996 Jun; 306(1-3):15-22. PubMed ID: 8813610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs.
    Lang A; Vasar E; Soosaar A; Harro J
    Pharmacol Toxicol; 1992 Aug; 71(2):132-8. PubMed ID: 1332017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
    Monnet FP; Debonnel G; Fournier A; de Montigny C
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors.
    Lynch DR; Gallagher MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):154-61. PubMed ID: 8858988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
    White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
    Levant B; Nemeroff CB
    J Pharmacol Exp Ther; 1990 Jul; 254(1):330-5. PubMed ID: 1973198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered.
    Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA
    Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.